PMC:7121452 / 8623-8857 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"265","span":{"begin":44,"end":48},"obj":"Gene"},{"id":"266","span":{"begin":220,"end":225},"obj":"Gene"},{"id":"269","span":{"begin":209,"end":219},"obj":"Species"}],"attributes":[{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"Gene:59272"},{"id":"A266","pred":"tao:has_database_id","subj":"266","obj":"Gene:43740568"},{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T28","span":{"begin":88,"end":94},"obj":"Body_part"},{"id":"T29","span":{"begin":226,"end":233},"obj":"Body_part"}],"attributes":[{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma9637"},{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T16","span":{"begin":88,"end":94},"obj":"Body_part"}],"attributes":[{"id":"A16","pred":"uberon_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T28","span":{"begin":209,"end":217},"obj":"Disease"}],"attributes":[{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T83","span":{"begin":59,"end":67},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T89","span":{"begin":26,"end":36},"obj":"Chemical"},{"id":"T90","span":{"begin":226,"end":233},"obj":"Chemical"}],"attributes":[{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}

{"project":"LitCovid-sentences","denotations":[{"id":"T32","span":{"begin":0,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Furthermore, even if RAAS inhibitors modify ACE2 levels or activity (or both) in target tissue beds, clinical data are lacking to indicate whether this would in turn facilitate greater engagement and entry of SARS-CoV-2 spike protein."}